Journal
CELL DEATH AND DIFFERENTIATION
Volume 18, Issue 2, Pages 248-258Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/cdd.2010.91
Keywords
p53 isoforms; splice; cancer; DNA damage; apoptosis; cell cycle
Categories
Funding
- Breast Cancer Campaign
- MRC
- Inserm (Institut National de la Sante Et de la Recherche Medicale)
- Ligue Nationale Contre le Cancer
- Cancer-Research, UK
Ask authors/readers for more resources
We have previously reported that the human p53 gene encodes at least nine different p53 isoforms, including Delta 133p53 alpha, which can modulate p53 transcriptional activity and apoptosis. In this study, we aimed to investigate the regulation of Delta 133p53 alpha isoform expression and its physiological role in modulating cell cycle arrest and apoptosis. We report here that in response to a low dose of doxorubicin (which induces cell cycle arrest without promoting apoptosis), p53 directly transactivates the human p53 internal promoter, inducing Delta 133p53 alpha protein expression. The induced Delta 133p53 alpha then inhibits p53-dependent apoptosis and G1 arrest without inhibiting p53-dependent G2 arrest. Therefore, endogenous Delta 133p53 alpha does not exclusively function in a dominant-negative manner toward p53, but differentially regulates cell cycle arrest and apoptosis. Cell Death and Differentiation (2011) 18, 248-258; doi: 10.1038/cdd.2010.91; published online 6 August 2010
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available